Kraig Biocraft Laboratories Inc (KBLB)

[arachnodude]

While you keep painting negativity, reality is where I'll go...

This information paints a picture of Mr. T's exceptional commitment to KBLB and his willingness to defer personal financial gain for the sake of the company’s survival and growth. Let’s break this down into key takeaways:

1. Deferred Salary Demonstrates Sacrifice

From 2011 through 2023, Kim Thompson consistently deferred a significant portion (and sometimes the entirety) of his salary to conserve company resources. His unpaid compensation has accrued to $3.5 million, reflecting years of financial sacrifice.

Instead of demanding immediate payment, Thompson deferred earnings to keep KBLB afloat during cash-constrained periods. His willingness to defer salary at significant personal expense (even as it accrued modest interest) is a testament to his dedication to the company’s vision.

2. Declined Benefits

Thompson also declined life and disability insurance benefits to further conserve company cash, an uncommon move for someone in his position.

This underscores a deep prioritization of company resources over personal perks or entitlements.

3. Financial Support Through Loans

On top of deferring salary, Thompson personally loaned the company millions, accruing additional interest of $2.6 million. This reflects not only financial commitment but confidence in the company’s future success.

CEOs lending significant personal funds to their companies is rare in the corporate world, particularly in a high-risk field like biotechnology.

4. A Long-Term Vision at Personal Expense

By deferring salary and providing loans, Thompson has aligned his financial well-being with the company’s success. He has:

—Forgone immediate earnings to fund the company’s operations.

—Tied the repayment of his compensation and loans to the company’s financial health and eventual profitability.

This is a far cry from the narrative some critics try to spin about him "lining his pockets." His actions show that he has continuously prioritized the company’s survival and development over personal enrichment.

5. Accrued Interest and Payable Balances

Yes, the deferred salaries and loans have accrued interest (as expected), but this is entirely standard in such arrangements. The 3% annual interest rate is modest, especially compared to the potential costs of external financing or dilution.

This setup ensures Thompson is eventually compensated fairly without forcing the company to take on high-interest debt from third-party sources or dilute shareholder equity prematurely.

6. Negative Narratives Fall Flat

Critics who argue that Thompson is overpaid or self-serving ignore these critical facts:

—Thompson’s actual take-home salary over the years has been minimal.

—His deferred compensation and loans demonstrate his skin in the game and confidence in KBLB’s eventual success.

Far from draining company resources, Thompson has preserved them, often at great personal cost.

Conclusion

Mr. T’s actions reflect a CEO who has been all-in for nearly two decades, putting the company’s success ahead of personal enrichment. Critics who harp on his current salary ignore the years of deferred compensation and the substantial financial sacrifices he has made. This long-term alignment with KBLB’s goals should be seen as a strength, not a weakness.

When the company achieves large-scale commercialization, these deferred payments will be a fraction of the value created—a testament to Thompson’s commitment and foresight. Anyone spinning this as greed is either misinformed or intentionally misleading.